Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Research Center, |
RCV000662015 | SCV000784347 | uncertain significance | Retinitis pigmentosa 38 | 2018-03-05 | criteria provided, single submitter | clinical testing | |
3billion | RCV000662015 | SCV002058279 | uncertain significance | Retinitis pigmentosa 38 | 2022-01-03 | criteria provided, single submitter | clinical testing | Same nucleotide change resulting in same amino acid change has been previously reported to be associated with MERTK related disorder (PMID:24265693, PS1_P). In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.67, PP3_P). It is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.000012, PM2_M). Therefore, this variant is classified as uncertain significance according to the recommendation of ACMG/AMP guideline. |
Department of Ophthalmology and Visual Sciences Kyoto University | RCV000132663 | SCV000172614 | probable-pathogenic | Retinitis pigmentosa | no assertion criteria provided | not provided | Converted during submission to Likely pathogenic. | |
Medical Genetics Laboratory, |
RCV000132663 | SCV000926608 | likely pathogenic | Retinitis pigmentosa | 2018-04-01 | no assertion criteria provided | research |